logo
Sensible Biotechnologies Slashes Time Taken to Optimize Novel Cell-Based mRNA Therapeutics by More Than 90% with AI Platform Built on NVIDIA Technology

Sensible Biotechnologies Slashes Time Taken to Optimize Novel Cell-Based mRNA Therapeutics by More Than 90% with AI Platform Built on NVIDIA Technology

Business Wire12-06-2025
BOSTON--(BUSINESS WIRE)-- Sensible Biotechnologies, a biotechnology company pioneering a cell-based platform for the design and manufacturing of mRNA therapeutics, today announced an initiative to accelerate the development of next-generation mRNA medicines through AI-driven molecular design powered by NVIDIA accelerated computing and AI.
'By combining our cell-based platform with NVIDIA accelerated computing and AI, we're laying the foundation for programmable, high-performance RNA medicines.' Miroslav Gasparek, CEO and co-founder of Sensible Biotechnologies.
Sensible has developed a unique design, optimization, and manufacturing process for producing mRNA drugs within living cells. The mRNA platform, which can include a range of novel modifications, creates a pure and low-immunogenicity drug product, unlocking new therapeutic areas with safe, effective, affordable and repeatable mRNA therapeutics. This replaces traditional in vitro transcription methods, which are unable to meet the demands of next-generation therapies for cancer, rare diseases, gene editing, and other unmet medical needs.
To enable predictive and precise mRNA sequence design, Sensible's proprietary closed-loop AI-powered design and optimization platform models RNA folding from raw sequence to stable conformation. It integrates NVIDIA technology, including NVIDIA BioNeMo framework and NVIDIA NIM microservices on the NVIDIA DGX Cloud platform with NVIDIA Hopper GPUs, to apply physics-based simulations and machine learning to understand how RNA folds and behaves in complex biological environments.
Using DGX Cloud with NVIDIA H100 80 GB and double-precision performance, Sensible achieves over 11,000 simulation steps per second. This performance enables the team to screen multiple RNA candidates in parallel, reducing simulation runtimes from overnight to under an hour per sequence.
By incorporating NVIDIA technology, Sensible has cut its mRNA optimization cycles from 15 days to just one – a reduction of more than 90%. This efficiency enables faster iteration and informed sequence optimization, giving Sensible the ability to rapidly manipulate mRNA design space and advance the next generation of life-saving medicines.
'Producing therapeutic mRNA inside living cells requires solving intricate biological problems, from RNA folding to packaging,' said Krishna Motheramgari, PhD, Principal Computational Scientist at Sensible Biotechnologies. 'With advanced NVIDIA accelerated computing and AI, we can simulate these dynamics rapidly and accurately, accelerating our design cycle dramatically.'
'This technology integration brings us closer to our vision of rationally designed mRNA therapeutics,' said Miroslav Gasparek, Chief Executive Officer and co-founder of Sensible Biotechnologies. 'By combining our cell-based platform with NVIDIA accelerated computing and AI, we're laying the foundation for programmable, high-performance RNA medicines.'
About Sensible Biotechnologies, Inc.
Sensible Biotechnologies is developing the first cell-based platform for the design, optimization, and manufacturing of highly functional, low-immunogenic mRNA, unlocking the therapeutic potential of mRNA for pharma and biotech partners across a wide range of applications. Based in Boston, Oxford and Bratislava, Sensible has raised more than $13M from leading life science and deep tech investors, including Recode Ventures, BlueYard Capital, Kaya VC, Backed VC, Y Combinator, ZAKA VC, and Onsight – the VC fund founded by the co-founder of BioNTech, Christoph Huber, and the co-founder of ARM, Hermann Hauser.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Jim Cramer Discusses NVIDIA Return to China Market
Jim Cramer Discusses NVIDIA Return to China Market

Yahoo

timean hour ago

  • Yahoo

Jim Cramer Discusses NVIDIA Return to China Market

NVIDIA Corporation (NASDAQ:NVDA) is one of the stocks Jim Cramer recently discussed. Cramer discussed the company's business with China during the episode. He said: 'This morning, we learned that the US government is planning to take a 15% cut on all the AI chips that these two companies are currently selling to China. For NVIDIA, that means a 15% cut on the H20, which was their cutting-edge chip for AI a few years ago, something they were previously banned from selling in the PRC. The president then said that NVIDIA might be getting approval to sell a next-generation chip to the Chinese, something, wow, more like their current version, Blackwell, except it won't have as much computing power. We didn't expect that Blackwell could be allowed in China. This was a big deal that the market completely just ignored. That was a mistake. President had asked for 20% cut of revenues, but NVIDIA CEO Jensen Huang bargained him down to 15%. That was good… NVDA Headquarters Courtesy of NVIDIA NVIDIA Corporation (NASDAQ:NVDA) designs GPUs, AI platforms, cloud services, and software for gaming, professional visualization, data centers, automotive, and robotics applications. While we acknowledge the potential of NVDA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

Dell, NVIDIA, Elastic Partner to Enhance AI Data Platform
Dell, NVIDIA, Elastic Partner to Enhance AI Data Platform

Yahoo

timean hour ago

  • Yahoo

Dell, NVIDIA, Elastic Partner to Enhance AI Data Platform

NVIDIA Corporation (NASDAQ:NVDA) is one of the best high-volume stocks to invest in. On August 12, Dell Technologies Inc. (NYSE:DELL) announced a partnership with NVIDIA and Elastic (NYSE:ESTC) to enhance its AI Data Platform, which is designed to help enterprises build and scale AI workloads. The platform is intended to accelerate workflows and break down data silos and integrates Dell PowerEdge R7725 servers, which are equipped with Nvidia's RTX PRO 6000 Blackwell Server Edition GPUs for high-performance AI workloads. This hardware will become globally available later in the year. The collaboration also brings in Elastic's Elasticsearch technology to enable natural language and vector search capabilities. A close-up of a colorful high-end graphics card being plugged in to a gaming computer. Furthermore, Nvidia's Omniverse libraries and AI models will be used to streamline searches within large 3D asset libraries. Vrashank Jain, a product director at Dell, noted that this collaboration will provide a shortcut to greater AI-based efficiency that companies crave. NVIDIA Corporation (NASDAQ:NVDA) is a computing infrastructure company that provides graphics and compute & networking solutions internationally Dell Technologies Inc. (NYSE:DELL) designs, develops, manufactures, markets, sells, and supports various comprehensive and integrated solutions, products, and services internationally. Elastic (NYSE:ESTC) is a search AI company that provides software platforms to run in hybrid, public, or private clouds and multi-cloud environments internationally. While we acknowledge the potential of NVDA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio

TSMC to Phase Out 6-Inch Wafer Business to Improve Efficiency
TSMC to Phase Out 6-Inch Wafer Business to Improve Efficiency

Yahoo

timean hour ago

  • Yahoo

TSMC to Phase Out 6-Inch Wafer Business to Improve Efficiency

Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is one of the best high-volume stocks to invest in. On August 12, TSMC announced a 2-year plan to phase out its 6-inch wafer manufacturing business. The company stated that this decision, made after a thorough evaluation of market conditions, is aligned with its long-term business strategy to improve efficiency. TSMC is also continuing to consolidate its 8-inch wafer production capacity. The company has only one 6-inch wafer fabrication plant and four 8-inch fabs in Taiwan, which are used for mature-node chip manufacturing. The production of advanced-node chips for major customers like Apple Inc. (NASDAQ:AAPL) and Nvidia Corp. (NASDAQ:NVDA) takes place in its 12-inch fabs. A close-up of a complex network of integrated circuits used in logic semiconductors. According to TSMC, this move will not affect its previously announced financial targets. The company is working with its customers to ensure a smooth transition and remains committed to meeting their needs during this period. In July, TSMC projected that its revenue would increase by about 30% for the year. Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) is a technology company that manufactures, packages, tests, and sells ICs and other semiconductor devices in Taiwan, China, Europe, the Middle East, Africa, Japan, the US, and internationally. While we acknowledge the potential of TSM as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store